Solstein Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Solstein Capital's PFE Position: Q1 2026 in Review
Solstein Capital held its Pfizer (PFE) position steady in Q1 2026 at 2,903 shares worth $81.5K. The position accounts for 0.03% of the portfolio, ranked #192.
Solstein Capital first reported a position in PFE in Q4 2019 and has held it in 25 quarters since. The position peaked at $251K in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Solstein Capital held 2,903 shares of Pfizer worth $81.5K as of Q1 2026.
- Solstein Capital left its Pfizer share count unchanged in Q1 2026.
- Pfizer made up 0.03% of Solstein Capital's portfolio in Q1 2026, its #192 holding.
- Solstein Capital first reported a position in Pfizer in Q4 2019 and has held it in 25 quarters since.
- Solstein Capital's Pfizer position peaked at $251K in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Solstein Capital's 13F filing for Q1 2026, filed 14 May 2026.